open access
New aspects of pharmacotherapy in acute heart failure
open access
Abstract
The prognosis in heart failure patients is poor. Mortality at five years is 25% and is higher than in patients with myocardial infarction and some cancers. Despite major progress in chronic heart failure management (Evidence Based Medicine) the treatment of acute heart failure is still empirical. Large multi-centre studies on the pharmacotherapy of acute heart failure are still lacking. The authors discuss management in acute heart failure concerning guidelines of the European Society of Cardiology from 2005 and modern pharmacotherapy.
Abstract
The prognosis in heart failure patients is poor. Mortality at five years is 25% and is higher than in patients with myocardial infarction and some cancers. Despite major progress in chronic heart failure management (Evidence Based Medicine) the treatment of acute heart failure is still empirical. Large multi-centre studies on the pharmacotherapy of acute heart failure are still lacking. The authors discuss management in acute heart failure concerning guidelines of the European Society of Cardiology from 2005 and modern pharmacotherapy.
Keywords
acute heart failure; pharmacotherapy of acute heart failure
About this articleTitle
New aspects of pharmacotherapy in acute heart failure
Journal
Issue
Vol 13, No 4 (2006): Folia Cardiologica
Article type
Review Article
Pages
275-281
Published online
2006-04-24
Page views
498
Article views/downloads
945
DOI
10.5603/cj.21811
Bibliographic record
Folia Cardiol 2006;13(4):275-281.
Keywords
acute heart failure
pharmacotherapy of acute heart failure
Authors
Anna Libionka
Jadwiga Nessler
